Methenamine Hippurate in UTI management: a reemerging pharmacological strategy

Mehwash Nadeem^{1

2}, Hashim Hashim^{3

4

5

6}

Affiliations

¹ Consultant Urological Surgeon and Lead for Complex UTI, James Cook University Hospital, Middlesbrough, UK.
² Newcastle University, UK.
³ Consultant Urological Surgeon & Director of the Urodynamics Unit, Bristol Urological Institute.
⁴ Tabriz University of Medical Science.
⁵ University of Bristol.
⁶ Neurourology & Urodynamics and BJUI Compass.

Editorial

Mehwash Nadeem et al. Expert Rev Clin Pharmacol. 2024 Dec.

. 2024 Dec;17(12):1095-1098.

doi: 10.1080/17512433.2024.2445621. Epub 2024 Dec 23.

Mehwash Nadeem^{1

2}, Hashim Hashim^{3

4

5

6}

¹ Consultant Urological Surgeon and Lead for Complex UTI, James Cook University Hospital, Middlesbrough, UK.
² Newcastle University, UK.
³ Consultant Urological Surgeon & Director of the Urodynamics Unit, Bristol Urological Institute.
⁴ Tabriz University of Medical Science.
⁵ University of Bristol.
⁶ Neurourology & Urodynamics and BJUI Compass.

No abstract available

Keywords: Urinary tract infection; antimicrobial resistance; formaldehyde; methenamine; recurrent UTI; urinary antiseptic.

Publication types